| Taxol, a microtubule stabilizer, improves cardiac contractile function during ischemia in vitro. | |
| | |
MedLine Citation:
|
PMID: 20453554 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Ischemic heart disease is one of the leading causes of heart failure, and microtubule disruption has been implicated in the response to ischemia in cardiac myocytes. The present study was designed to explore the effects of taxol, a microtubule stabilizer, on cardiac contractile function during ischemia. Heart rate, left ventricular developed pressure, left ventricular end-diastolic pressure, maximal time derivatives of pressure and work index were analyzed in isolated rat or rabbit hearts during ischemia. In addition, intracellular calcium concentrations ([Ca(2+)](i)) and Ca(2+) transients were examined by Fura-2-AM and Fluo-3-AM, respectively. Reactive oxygen species (ROS) and oxidative enzyme activities were measured with fluorometric or spectrophotometric techniques. It was found that taxol could improve the cardiac contractile function during ischemia. This effect was identified based on a blunting of the decrease in heart rate, left ventricular developed pressure, maximal time derivatives of pressure and work index during ischemia, which might be related to the preservation of calcium homeostasis and ROS levels. The preservation of calcium homeostasis included a decrease in the rise of [Ca(2+)](i) and maintenance of the amplitude and decay time of Ca(2+) transients. The reduction in ROS levels was associated with increased activity of mitochondrial electron transport chain complex I and complex III. In conclusion, taxol could effectively improve the cardiac contractile function during ischemia by preserving calcium homeostasis and ROS levels. This study presents evidence that taxol could represent a novel approach to drug development for heart failure. |
| | |
Authors:
|
Junjie Xiao; Hong Zhao; Dandan Liang; Ying Liu; Hong Zhang; Yi Liu; Jun Li; Luying Peng; Zhaonian Zhou; Yi-Han Chen |
Related Documents
:
|
9769234 - Depressed myofilament co-operativity associated with post-cardioplegic myocardial depre... 22282714 - The differential diagnosis and treatment of normal-pressure hydrocephalus. 1582004 - Alterations in intestinal permeability and blood flow in a new model of mesenteric isch... 2167254 - Use of spin traps in intact animals undergoing myocardial ischemia/reperfusion: a new a... 3377044 - Comparison of intraocular pressure measurements with the oculab tono-pen vs manometry i... 19834344 - Assessment of arterial stiffness in hypertension: comparison of oscillometric (arteriog... |
Publication Detail:
|
Type: In Vitro; Journal Article; Research Support, Non-U.S. Gov't Date: 2010-05-07 |
Journal Detail:
|
Title: Pharmacology Volume: 85 ISSN: 1423-0313 ISO Abbreviation: Pharmacology Publication Date: 2010 |
Date Detail:
|
Created Date: 2010-06-02 Completed Date: 2010-09-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0152016 Medline TA: Pharmacology Country: Switzerland |
Other Details:
|
Languages: eng Pagination: 301-10 Citation Subset: IM |
Copyright Information:
|
Copyright 2010 S. Karger AG, Basel. |
Affiliation:
|
Department of Cardiology, East Hospital, Tongji University School of Medicine, Shanghai, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Calcium Signaling / drug effects Cells, Cultured Electron Transport Chain Complex Proteins / metabolism Heart Failure / drug therapy Heart Ventricles / cytology, drug effects, metabolism, physiopathology Homeostasis / drug effects Male Microtubules / physiology* Mitochondria, Heart / drug effects, enzymology Myocardial Contraction / drug effects* Myocardial Ischemia / drug therapy*, metabolism, physiopathology Myocytes, Cardiac / drug effects, enzymology, metabolism Paclitaxel / therapeutic use* Rabbits Rats Rats, Sprague-Dawley Reactive Oxygen Species / metabolism Time Factors Tubulin Modulators / therapeutic use* Ventricular Dysfunction, Left / drug therapy |
| Chemical | |
Reg. No./Substance:
|
0/Electron Transport Chain Complex Proteins; 0/Reactive Oxygen Species; 0/Tubulin Modulators; 33069-62-4/Paclitaxel |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The Roles of T-Type Calcium Channel in the Development of Neuropathic Pain following Chronic Compres...
Next Document: Concomitant Activity of Histamine and Cysteinyl Leukotrienes on Porcine Nasal Mucosal Vessels and Na...